1. cyberspacer
2. snezhinka4
3. craymonk
4. captureME
5. robindo
1.craymonk 01/31/2018
Started a nice position today.
2.robindo 03/26/2018
Canaccord Genuity resumes coverage as a buy, $210PT
3.cyberspacer 01/31/2018
BIG news out!!! - Announces SAGE-217 meets primary endpoint; co expects to initiate clinical development of SAGE-217 in disord…
4.cyberspacer 12/08/2017
MC is $6.4 bil
5.cyberspacer 02/07/2018
Receives FDA Breakthrough Therapy Designation for SAGE-217 for the Treatment of Major Depressive Disorder
6.captureME 02/07/2018
Commences $575 mln common stock offering
7.snezhinka4 04/10/2018
Deal rumors swirling following headlines that the company has cancelled out of an upcoming conference presen…
8.craymonk 12/08/2017
Wow, out of the loop
9.captureME 12/07/2017
This Biotech Catapults 70% Higher On Depression Drug Results
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW